High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition - Wikidata - wikimedia - TriplyDB

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

http://www.wikidata.org/entity/Q33750221

about

High expression of CD109 antigen regulates the phenotype of cancer stem-like cells/cancer-initiating cells in the novel epithelioid sarcoma cell line ESX and is related to poor prognosis of soft tissue sarcoma Salinomycin as a drug for targeting human cancer stem cells Immune targeting of cancer stem cells in gastrointestinal oncology Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations.Aromatase Inhibitor-Mediated Downregulation of INrf2 (Keap1) Leads to Increased Nrf2 and Resistance in Breast Cancer Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells The multiple facets of drug resistance: one history, different approaches.Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse study Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma Effects of curcumin on stem-like cells in human esophageal squamous carcinoma cell lines Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1 Comparison of cancer stem cell antigen expression by tumor cell lines and by tumor biopsies from dogs with melanoma and osteosarcoma Epigenetic reprogramming and re-differentiation of a Ewing sarcoma cell line Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.3D tissue-engineered model of Ewing's sarcoma Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.High neuropeptide Y release associates with Ewing sarcoma bone dissemination - in vivo model of site-specific metastases Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells Stemness of B-cell progenitors in multiple myeloma bone marrow.Identification of CD146 as a marker enriched for tumor-propagating capacity reveals targetable pathways in primary human sarcoma Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype MicroRNAs in Ewing Sarcoma.Stem-like cells in bladder cancer cell lines with differential sensitivity to cisplatin.Englerin A Inhibits EWS-FLI1 DNA Binding in Ewing Sarcoma Cells A dose-finding study of temsirolimus and liposomal doxorubicin for patients with recurrent and refractory bone and soft tissue sarcoma.The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.Cancer stem cells in breast cancer.A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression.Characterization of a novel transgenic mouse tumor model for targeting HER2+ cancer stem cells.The miR-106b~25 cluster promotes bypass of doxorubicin-induced senescence and increase in motility and invasion by targeting the E-cadherin transcriptional activator EP300.Hypoxia shifts activity of neuropeptide Y in Ewing sarcoma from growth-inhibitory to growth-promoting effects.ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.Sarcoma stem cells: do we know what we are looking for?Insulin-like growth factor 1 receptor as a therapeutic target in ewing sarcoma: lack of consistent upregulation or recurrent mutation and a review of the clinical trial literature.

P2860

Q21132376-63C3AE4D-D5D2-44A7-BB92-0BE35F9C8DF7 Q21285139-916FA18C-FA09-4326-A089-5946B4576A0C Q26749015-57A69C88-7C8F-4653-82AE-4FA6CC344323 Q27342050-91028A78-9ACA-4D36-B483-831E106F6A8C Q28383028-8639C75A-8E51-4CE0-845C-5A3FA897E109 Q28482489-6B6EA03E-3DBA-493D-9737-418D71EDBA62 Q33275167-6B1556F4-080F-4E8C-AB18-7667E20BE37A Q33688502-33FE4616-358A-42F9-9B6E-2EBED0FE260D Q33697116-313E48A0-25CE-403F-9C69-FE84515B7E5E Q33863903-D1FACDAF-33A4-4C01-BB3F-7668AD402892 Q33997274-E1EFA962-11ED-4B11-B0B7-5EBD793B23DE Q34220071-336B0949-3583-4582-B48A-FFAF516D51D4 Q34354781-64FA2E95-2A90-462D-A9BE-7A5A24123E4D Q34457148-A4E48DF2-339A-4C15-A3DC-F68B774BEAC7 Q34486691-0BA9BD97-67A3-48E0-98A9-BE28ED9974F5 Q34688250-FE13C12A-8B28-464A-B56F-094BE96EC42A Q35158389-75DB5EEE-1847-4AB2-A26F-A4359A3F5FD6 Q35177969-C70FFAF4-A4CA-4CD7-A0E6-2C3702DA783A Q35428655-E6921CF2-A8FB-4554-A2F3-31D2DBE758B5 Q35615455-59F65A11-7EB7-40DD-85C1-82CE110632D2 Q35740170-FF117010-B27E-4929-9C35-1193C16E7EFD Q36060236-3FD0BCDC-918E-4413-BFDA-43DFA4B8798D Q36405908-0F87D763-DCBD-44A4-9CD9-226EACE0B242 Q36545600-7BDFB59E-F088-4EED-B05B-3CD940586648 Q36586203-7B3FDD7F-9006-4877-9A15-026F004890B3 Q36660550-59AD88E1-BF42-4727-B0FF-DD006191E29A Q36722134-22A57304-070E-4775-B4AC-3899642AD7AB Q36802896-49625A66-1A0F-485B-9DA3-973BB2A27D38 Q36876146-F480E744-A29B-41BE-A2AA-8DA144146696 Q36926895-BBDF2075-A6A2-47E2-9724-86818007C778 Q37043780-3EF62271-DFAA-4584-8B2F-4F716045ACAF Q37129887-F827F283-B2F7-46DB-9862-BB13CA7FC1F2 Q37269467-788B160E-1D02-4E18-9742-AFAE16955361 Q37362571-B52FF4DB-2FDE-4597-9A00-F8B4C3432A7E Q37428738-D1C22408-DBBF-44A5-9AAA-F46BC6765254 Q37578813-070E008D-A6FC-4713-B093-0292727CFC4B Q37589156-9951BFFF-974A-4267-BF86-9893589D3F4F Q37625131-97AD477D-1E6D-465B-BCD2-89A7CC4E7194 Q38015339-8D06A817-516F-4004-AC57-FCB09F476838 Q38083655-ACF5DF5D-B136-4CC6-883B-8BF7C83E0448

P2860

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

http://www.wikidata.org/entity/Q33750221

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@ast

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@en

type

label

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@ast

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@en

prefLabel

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@ast

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@en

P1433

Q33750221-1BC63DB1-FD24-4D83-B6F8-463C0E7220CE

P1476

Q33750221-3FE44E1A-5309-406A-B22C-E58492894996

P2093

Q33750221-17BDDBAA-3D2B-46BD-B462-1A91D66E0038

Q33750221-3CCBD26B-9E52-4296-89B1-CFE56E7CC533

Q33750221-458EEC50-05BB-445E-9C56-5BA259A80679

Q33750221-5BC69589-19B4-4CA9-9730-15398682C46F

Q33750221-93D7B9FE-DCD4-4E58-AFE3-C90E15F8A449

Q33750221-9DCDC760-641F-4A9C-9A12-E924CA469F9E

Q33750221-A2F649C6-1EC9-49EB-9557-A4CD57E88F9F

Q33750221-ACD04D1D-EC4A-4994-9080-C2B0EE0B77BE

Q33750221-EBF174F8-BABE-4B3C-BA15-0AB63976A95E

Q33750221-FFDBD89C-211B-4DCE-A0E4-F300F16C4903

P2860

Q33750221-0203BCB5-74C7-45BE-A146-93219FAFDC78

Q33750221-04F502D4-7D9B-4D3A-A6CD-B1E281096B4F

Q33750221-074AF39E-45CA-4140-A089-174391B60A45

Q33750221-0BB4070A-9616-42F6-ACC2-BA6A916EA5F1

Q33750221-11047F1C-F940-454B-8A65-C5C6EA4426F3

Q33750221-15B1A42E-48FF-4E06-90AE-CA4362B56E8A

Q33750221-17C36BAF-8FCA-4D82-A765-E14E2B86B6E1

Q33750221-21FD03F3-DDAB-4849-98FE-74616AE4469D

Q33750221-27537DF2-31D7-4A29-B296-629FB5345242

Q33750221-394FC031-5D29-4AA5-8848-7FC0FB0F5AB2

P304

Q33750221-6ACE3A68-FB8B-434D-BBD3-9B40500D7263

P31

Q33750221-78F79C08-D734-466F-9074-4DC4CF35D89C

P356

Q33750221-34BF4C37-39F4-49DB-9FD5-30CA32EB8B87

P407

Q33750221-5BEE8650-B099-458D-95F0-99D852131660

P433

Q33750221-AFC18885-053D-4462-8C54-195CF4999332

P478

Q33750221-E2078741-5074-4735-93B3-64441AD9F95A

P577

Q33750221-45E42382-7C1D-4B30-9026-084574B8555D

P5875

Q33750221-486C5BDC-0A6A-42E2-99AA-BA5B7D31CDB9

P698

Q33750221-DBD3CC6C-5B8D-4EAD-AE2E-45047EFF6045

P921

Q33750221-21E1CDD4-5090-4F68-B0BD-9479B15D00ED

P932

Q33750221-BE56A8A4-86C1-45BC-9537-F7B3F2A561FF

P356

JOURNAL.PONE.0013943

P1433

P1476

High ALDH activity identifies ...... itivity to EWS-FLI1 inhibition

@en

P2093

Alison O'Neill

http://www.w3.org/2001/XMLSchema#string

David M Loeb

http://www.w3.org/2001/XMLSchema#string

Jason T Yustein

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Toretsky

http://www.w3.org/2001/XMLSchema#string

Milton L Brown

http://www.w3.org/2001/XMLSchema#string

Naheed Gul

http://www.w3.org/2001/XMLSchema#string

Ola Awad

http://www.w3.org/2001/XMLSchema#string

Preeti Shah

http://www.w3.org/2001/XMLSchema#string

Varalakshmi Katuri

http://www.w3.org/2001/XMLSchema#string

Yali Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Prospective identification of tumorigenic breast cancer cells

Identification and expansion of human colon-cancer-initiating cells

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Identification of a cancer stem cell in human brain tumors

P304

e13943

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0013943

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47812972

http://www.w3.org/2001/XMLSchema#string

P698

21085683

http://www.w3.org/2001/XMLSchema#string

P921

P932

2978678

http://www.w3.org/2001/XMLSchema#string